Drug recall D-1445-2014
Product
Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.
Reason for recall
Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.
Lots and codes
Lot # DM1316; Exp. 05/16 Lot # DM1318; Exp. 05/16
Recall details
- Recalling firm
- Sandoz Inc, Princeton, NJ
- Quantity
- 781,000 extended release tablets
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 11, 2014
- Terminated
- July 10, 2017
Related products
- Orphenadrine citrate – drug information
- NDC 0185-0022 Orphenadrine Citrate · Orphenadrine Citrate 100 mg/1 · Sandoz Inc